FDA Approved: BAXDELA — Original Application (Melinta Therapeutics, LLC)

View source ↗

Summary

The FDA approves Baxdela (delafloxacin meglumine) for the treatment of acute bacterial skin and skin structure infections, with an additional indication for com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections
• Community-acquired Bacterial Pneumonia

Drugs mentioned

• BAXDELA (delafloxacin meglumine)

Snippet

ORIG AP for BAXDELA (DELAFLOXACIN MEGLUMINE)